Why is Cochlear stock sliding today?
Cochlear's stock declined by up to 2.4% to A$141.67 on Tuesday following the filing of a shareholder class action lawsuit in the Supreme Court of Victoria. The legal dispute alleges that the company did not sufficiently disclose business challenges in its FY26 profit forecast prior to a significant guidance downgrade earlier in the year.
Cochlear maintains its innocence and aims to fight the allegations. The class action applies to investors who purchased Cochlear shares between 15 August 2025 and 21 April 2026, the period during which the company continued to forecast higher profits that it later drastically revised downwards. In April 2026, Cochlear revised its FY26 underlying net profit outlook from A$435–460 million to A$290–330 million, citing lower-than-expected implant sales and increased uncertainty stemming from the conflict in the Middle East.
This downward revision sparked a roughly 40% one-day drop in the share price. The Australian market did not offer much relief, as the S&P/ASX 200 opened only slightly higher on Tuesday before the Reserve Bank of Australia's anticipated decision on interest rates.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
